Giannopoulos Stefanos, Texakalidis Pavlos, Jonnalagadda Anil Kumar, Karasavvidis Theofilos, Giannopoulos Spyridon, Kokkinidis Damianos G
251 HAF and VA Hospital, Athens, Greece.
Aristotle University of Thessaloniki, Thessaloniki, Greece.
Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):638-644. doi: 10.1016/j.carrev.2018.01.014. Epub 2018 Jan 31.
The incidence of carotid artery stenosis after head and neck radiation is anticipated to rise due to the increasing survival of patients with head and neck malignancies. It remains unclear whether carotid artery stenting (CAS) or endarterectomy (CEA) is the best treatment strategy for radiation-induced carotid artery stenosis.
MATERIALS & METHODS: This study was performed according to the PRISMA and MOOSE guidelines. Eligible studies were identified through a comprehensive search of PubMed, Scopus and Cochrane Central until July 20, 2017. A meta-analysis of random effects model was conducted. The I-square statistic was used to assess for heterogeneity.
Five studies and 143 patients were included. Periprocedural stroke, myocardial infarction (MI) and death rates were similar between the two revascularization approaches. However, the risk for cranial nerve (CN) injury was higher in the CEA group (OR: 7.09; 95% CI: 1.17-42.88; I = 0%). CEA was associated with lower mortality rates after a mean follow-up of 50 months (OR: 0.29; 95% CI: 0.09-0.97; I = 0%). No difference was identified in long-term restenosis rates between CEA and CAS.
Patients with radiation-induced carotid artery stenosis can safely undergo both CAS and CEA with similar risks of periprocedural stroke, MI and death. However, patients treated with CEA have a higher risk for periprocedural CN injuries and a lower risk for long-term mortality.
由于头颈部恶性肿瘤患者生存率的提高,预计头颈部放疗后颈动脉狭窄的发生率将会上升。目前尚不清楚颈动脉支架置入术(CAS)或颈动脉内膜切除术(CEA)是否是治疗放疗所致颈动脉狭窄的最佳策略。
本研究按照PRISMA和MOOSE指南进行。通过全面检索PubMed、Scopus和Cochrane Central直至2017年7月20日来确定符合条件的研究。进行随机效应模型的荟萃分析。使用I²统计量评估异质性。
纳入5项研究共143例患者。两种血运重建方法的围手术期卒中、心肌梗死(MI)和死亡率相似。然而,CEA组的颅神经(CN)损伤风险更高(比值比:7.09;95%置信区间:1.17 - 42.88;I² = 0%)。平均随访50个月后,CEA与较低的死亡率相关(比值比:0.29;95%置信区间:0.09 - 0.97;I² = 0%)。CEA和CAS之间的长期再狭窄率无差异。
放疗所致颈动脉狭窄患者可安全地接受CAS和CEA,围手术期卒中、MI和死亡风险相似。然而,接受CEA治疗的患者围手术期CN损伤风险较高,长期死亡风险较低。